Dosage and administration
adults and children 6 years of age and over: put 1 or 2 drops in the affected eye(s) up to four times a day children under 6 years of age: consult a doctor
adults and children 6 years of age and over: put 1 or 2 drops in the affected eye(s) up to four times a day children under 6 years of age: consult a doctor
store at 15° to 25°C (59° to 77°F)
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Naphazoline HCl 0.025% | Redness reliever |
| Pheniramine maleate 0.3% | Antihistamine |
Temporarily relieves itchy, red eyes due to:
For external use only
Do not use if you are sensitive to any ingredient in this product
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Accidental swallowing by infants and children may lead to coma and marked reduction in body temperature.
benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate, sodium hydroxide and/or hydrochloric acid
call toll-free 888-734-7648 or 215-273-8755 (collect)
Distributed by:
JOHNSON & JOHNSON CONSUMER INC.
Skillman, NJ 08558
DRUG: Visine A Multi-Action Eye Allergy Relief Multi-Action Eye Allergy Relief
GENERIC: Naphazoline Hydrochloride and Pheniramine Maleate
DOSAGE: SOLUTION/ DROPS
ADMINSTRATION: OPHTHALMIC
NDC: 70518-1729-0
PACKAGING: 15 mL in 1 BOTTLE, DROPPER
OUTER PACKAGING: 1 in 1 CARTON
ACTIVE INGREDIENT(S):
INACTIVE INGREDIENT(S):
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Data code | Data Matrix | DUMMY BARCODE QUERY STRING DUMMY BARCODE QUERY STRING DUMMY BARCODE QUERY STRING DUMMY BARCODE QUERY STRING DUMMY BARCODE QUERY STRING | Remedy_Label.jpg |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69968-0063-1 | ML - Milliliter | 69968-0063 | 8fa6c881-b710-4ebf-9595-d26eb3fac2a2 | 1 | 2018-03-08 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 70518-1729 | 70518-1729-0 |
| 69968-0063 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BORIC ACID | R57ZHV85D4 | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| WATER | 059QF0KO0R | IACT |
| NAPHAZOLINE HYDROCHLORIDE | MZ1131787D | ACTIB |
| PHENIRAMINE MALEATE | NYW905655B | ACTIB |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020485-001 | VISINE | NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N020485-001 | VISINE | 0.025%;0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1996-01-31 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a83a2725-cdd7-adaf-e053-2a95a90a3d88 | df01ce2b-fd0d-4970-9a44-df30d817b94d | 2020-06-16 | Warnings | df01ce2b-fd0d-4970-9a44-df30d817b94d |
Adverse event summaries are temporarily unavailable. Other product information remains available.